Cargando…

The need for GIScience in mapping COVID-19

Since first being tracked in China in late 2019, the effects of the COVID-19 coronavirus have shaped global patterns of morbidity and mortality, as well as exposed the strengths and limitations of health care systems and social safety nets. Without question, reporting of its impact has been bolstere...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenkrantz, Leah, Schuurman, Nadine, Bell, Nathaniel, Amram, Ofer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328589/
https://www.ncbi.nlm.nih.gov/pubmed/33526208
http://dx.doi.org/10.1016/j.healthplace.2020.102389
_version_ 1783552754306777088
author Rosenkrantz, Leah
Schuurman, Nadine
Bell, Nathaniel
Amram, Ofer
author_facet Rosenkrantz, Leah
Schuurman, Nadine
Bell, Nathaniel
Amram, Ofer
author_sort Rosenkrantz, Leah
collection PubMed
description Since first being tracked in China in late 2019, the effects of the COVID-19 coronavirus have shaped global patterns of morbidity and mortality, as well as exposed the strengths and limitations of health care systems and social safety nets. Without question, reporting of its impact has been bolstered in large part through near real-time daily mapping of cases and fatalities. Though these maps serve as an effective political and social tool in communicating disease impact, most visualizations largely over-emphasize their usefulness for tracking disease progression and appropriate responses. Messy and inconsistent health data are a big part of this problem, as is a paucity of high-resolution spatial data to monitor health outcomes. Another issue is that the ease of producing out-of-the box products largely out paces the response to the core challenges inherent in the poor quality of most geo-referenced data. Adopting a GIScience approach, and in particular, making use of location-based intelligence tools, can improve the shortcomings in data reporting and more accurately reveal how COVID-19 will have a long-term impact on global health.
format Online
Article
Text
id pubmed-7328589
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-73285892020-07-01 The need for GIScience in mapping COVID-19 Rosenkrantz, Leah Schuurman, Nadine Bell, Nathaniel Amram, Ofer Health Place Article Since first being tracked in China in late 2019, the effects of the COVID-19 coronavirus have shaped global patterns of morbidity and mortality, as well as exposed the strengths and limitations of health care systems and social safety nets. Without question, reporting of its impact has been bolstered in large part through near real-time daily mapping of cases and fatalities. Though these maps serve as an effective political and social tool in communicating disease impact, most visualizations largely over-emphasize their usefulness for tracking disease progression and appropriate responses. Messy and inconsistent health data are a big part of this problem, as is a paucity of high-resolution spatial data to monitor health outcomes. Another issue is that the ease of producing out-of-the box products largely out paces the response to the core challenges inherent in the poor quality of most geo-referenced data. Adopting a GIScience approach, and in particular, making use of location-based intelligence tools, can improve the shortcomings in data reporting and more accurately reveal how COVID-19 will have a long-term impact on global health. Elsevier Ltd. 2021-01 2020-07-01 /pmc/articles/PMC7328589/ /pubmed/33526208 http://dx.doi.org/10.1016/j.healthplace.2020.102389 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Rosenkrantz, Leah
Schuurman, Nadine
Bell, Nathaniel
Amram, Ofer
The need for GIScience in mapping COVID-19
title The need for GIScience in mapping COVID-19
title_full The need for GIScience in mapping COVID-19
title_fullStr The need for GIScience in mapping COVID-19
title_full_unstemmed The need for GIScience in mapping COVID-19
title_short The need for GIScience in mapping COVID-19
title_sort need for giscience in mapping covid-19
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328589/
https://www.ncbi.nlm.nih.gov/pubmed/33526208
http://dx.doi.org/10.1016/j.healthplace.2020.102389
work_keys_str_mv AT rosenkrantzleah theneedforgiscienceinmappingcovid19
AT schuurmannadine theneedforgiscienceinmappingcovid19
AT bellnathaniel theneedforgiscienceinmappingcovid19
AT amramofer theneedforgiscienceinmappingcovid19
AT rosenkrantzleah needforgiscienceinmappingcovid19
AT schuurmannadine needforgiscienceinmappingcovid19
AT bellnathaniel needforgiscienceinmappingcovid19
AT amramofer needforgiscienceinmappingcovid19